Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (Details 2)

v2.4.0.8
STOCKHOLDERS' EQUITY (Details 2) (USD $)
12 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Stock-based compensation expenses $ 1,257,300 $ 1,350,800
Cost Of Neurometric Services Revenues[Member]
   
Stock-based compensation expenses 10,600 10,200
Research Tax Credit Carryforward [Member]
   
Stock-based compensation expenses 92,700 99,200
Product Development [Member]
   
Stock-based compensation expenses 113,300 72,500
Selling and Marketing Expense [Member]
   
Stock-based compensation expenses 155,500 196,800
General and Administrative Expense [Member]
   
Stock-based compensation expenses $ 885,200 $ 972,100